Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Community Health
Published in: Journal of Community Health 5/2016

01-10-2016 | Original Paper

Promoting and Providing HPV Vaccination in Hawaii: Barriers Faced by Health Providers

Authors: Ashlyn Tom, Hali Robinett, Lee Buenconsejo-Lum, Reni Soon, Michael Hamilton, Pia Francisco-Natanauan, May Rose Dela Cruz, Ronald Balajadia, Brenda Y. Hernandez

Published in: Journal of Community Health | Issue 5/2016

Login to get access

Abstract

Despite the availability of HPV prophylactic vaccines, uptake has been suboptimal in the US. In the state of Hawaii, HPV vaccine coverage has decreased among females and remains low among males aged 13–17. The reasons for low uptake are unknown and may indicate the existence of critical barriers to HPV vaccination. The purpose of this investigation was to identify policy, system and environmental barriers and promoters of pediatric HPV vaccination in Hawaii. An online 86-item survey addressing knowledge, attitudes, beliefs, practices, and barriers to HPV vaccination was distributed to practicing physicians in Hawaii specializing in Pediatrics, Family Medicine, and Obstetrics-Gynecology. Survey responses were received from a total of 120 physicians. Private practice physicians reported more concerns with vaccine ordering and stocking costs (p < 0.0001), reimbursement levels (p < 0.0001), and insurance coverage (p < 0.0001) compared to physicians in large group practices. Eighty-three percent of providers cited lack of parent knowledge and understanding of HPV infection as a barrier. Over half of physicians (58 %) reported that completion of the 3-dose schedule was a barrier. Most physicians did not use tracking or reminder systems to ensure dose completion. A majority (58 %) of providers cited the lack of school-based vaccination requirements as a barrier. Uptake of HPV vaccination in Hawaii may be impeded by physician perception of parent knowledge and attitudes. Cost-related system barriers are particular barriers among those in private practice. Completion of the 3-dose schedule also remains a challenge.
Literature
1.
Reagan-Steiner, S., Yankey, D., Jeyarajah, J., Elam-Evans, L. D., Singleton, J. A., Curtis, C. R., et al. (2015). National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 years–United States, 2014. Morbidity and Mortality Weekly Report, 64(29), 784–792.CrossRefPubMed
2.
Forman, D., de Martel, C., Lacey, C. J., Soerjomataram, I., Lortet-Tieulent, J., Bruni, L., et al. (2012). Global burden of human papillomavirus and related diseases. Vaccine, 30, F12–F23.CrossRefPubMed
3.
Satterwhite, C. L., Torrone, E., Meites, E., Dunne, E. F., Mahajan, R., Ocfemia, M. C. B., et al. (2013). Sexually transmitted infections among US women and men: Prevalence and incidence estimates, 2008. Sexually Transmitted Diseases, 40(3), 187–193.CrossRefPubMed
4.
Cardoso, J., & Calonje, E. (2011). Cutaneous manifestations of human papillomaviruses: a review. Acta dermatovenerologica Alpina Pannonica et Adriatica, 20(3), 145–154.
5.
Centers for Disease Control and Prevention (CDC). (2010). FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). Morbidity and Mortality Weekly Report, 59(20), 626.
6.
Centers for Disease Control and Prevention (CDC). (2011). Recommendations on the use of quadrivalent human papillomavirus vaccine in males–Advisory Committee on Immunization Practices (ACIP), 2011. Morbidity and Mortality Weekly Report, 60(50), 1705.
7.
Petrosky, E., Bocchini, J., Hariri, S., Chesson, H., Curtis, C. R., Saraiya, M., et al. (2015). Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices. Morbidity and Mortality Weekly Report, 64(11), 300–304.PubMed
8.
Lu, B., Kumar, A., Castellsagué, X., & Giuliano, A. R. (2011). Efficacy and safety of prophylactic vaccines against cervical HPV infection and diseases among women: a systematic review and meta-analysis. BMC Infectious Diseases, 11(1), 1.CrossRef
9.
Centers for Disease Control and Prevention CDC. (2013). Human papillomavirus vaccination coverage among adolescent girls, 2007–2012, and post-licensure vaccine safety monitoring, 2006–2013-United States. Morbidity and Mortality Weekly Report, 62(29), 591.
10.
Stokley, S., Jeyarajah, J., Yankey, D., Cano, M., Gee, J., Roark, J., et al. (2014). Human papillomavirus vaccination coverage among adolescents, 2007–2013, and post-licensure vaccine safety monitoring, 2006–2014–United States. Morbidity and Mortality Weekly Report, 63(29), 620–624.PubMed
11.
Kash, N., Lee, M. A., Kollipara, R., Downing, C., Guidry, J., & Tyring, S. K. (2015). Safety and efficacy data on vaccines and immunization to human papillomavirus. Journal of Clinical Medicine, 4(4), 614–633.CrossRefPubMedPubMedCentral
12.
US Department of Health and Human Services. (2011). Healthy people 2020. Washington, DC: US Department of Health and Human Services; 2010.
13.
National Cancer Institute (US) (2014). Accelerating HPV vaccine uptake: urgency for action to prevent cancer. A report to the President of the United States from the President’s Cancer Panel. Bethesda, MD: National Cancer Institute.
14.
Elam-Evans, L. D., Yankey, D., Singleton, J. A., Kolasa, M., & Centers for Disease Control and Prevention. (2014). National, state, and selected local area vaccination coverage among children aged 19–35 months—United States, 2013. Morbidity and Mortality Weekly Report, 63(34), 741–748.PubMed
15.
Cates, J. R., Shafer, A., Carpentier, F. D., Reiter, P. L., Brewer, N. T., McRee, A., et al. (2010). How parents hear about human papillomavirus vaccine: Implications for uptake. Journal of Adolescent Health, 47(3), 305–308.CrossRefPubMedPubMedCentral
16.
Gargano, L. M., Herbert, N. L., Painter, J. E., Sales, J. M., Morfaw, C., Rask, K., et al. (2013). Impact of a physician recommendation and parental immunization attitudes on receipt or intention to receive adolescent vaccines. Human vaccines and immunotherapeutics, 9(12), 2627–2633.CrossRefPubMedPubMedCentral
17.
Allen, J. D., Othus, M. K., Shelton, R. C., Li, Y., Norman, N., Tom, L., et al. (2010). Parental decision making about the HPV vaccine. Cancer Epidemiology, Biomarkers and Prevention, 19(9), 2187–2198.CrossRefPubMed
18.
Brewer, N. T., Gottlieb, S. L., Reiter, P. L., McRee, A., Liddon, N., Markowitz, L., et al. (2011). Longitudinal predictors of HPV vaccine initiation among adolescent girls in a high-risk geographic area. Sexually Transmitted Diseases, 38(3), 197.CrossRefPubMedPubMedCentral
19.
Soon, R., Cruz, M. R. I. D., Tsark, J. U., Chen, J. J., & Braun, K. L. (2015). A Survey of physicians’ attitudes and practices about the human papillomavirus (HPV) vaccine in Hawai ‘i. Hawai’i Journal of Medicine and Public Health, 74(7), 234.PubMedPubMedCentral
20.
Tan, T. Q., Bhattacharya, L., & Gerbie, M. V. (2010). Awareness, perceptions and knowledge of recommended adult vaccines among a nationwide sample of adult primary care providers. The Journal of Reproductive Medicine, 56(7–8), 301–307.
21.
Kahn, J. A., Rosenthal, S. L., Tissot, A. M., Bernstein, D. I., Wetzel, C., & Zimet, G. D. (2007). Factors influencing pediatricians’ intention to recommend human papillomavirus vaccines. Ambulatory Pediatrics, 7(5), 367–373.CrossRefPubMed
22.
Young, J. L., Bernheim, R. G., Korte, J. E., Stoler, M. H., Guterbock, T. M., & Rice, L. W. (2011). Human papillomavirus vaccination recommendation may be linked to reimbursement: a survey of Virginia family practitioners and gynecologists. Journal of Pediatric and Adolescent Gynecology, 24(6), 380–385.CrossRefPubMed
23.
Freed, G. L., Cowan, A. E., Gregory, S., & Clark, S. J. (2008). Variation in provider vaccine purchase prices and payer reimbursement. Pediatrics, 122(6), 1325–1331.CrossRefPubMed
24.
Ruffin, M. T., Plegue, M. A., Rockwell, P. G., Young, A. P., Patel, D. A., & Yeazel, M. W. (2015). Impact of an electronic health record (EHR) reminder on human papillomavirus (HPV) vaccine initiation and timely completion. The Journal of the American Board of Family Medicine, 28(3), 324–333.CrossRefPubMed
25.
Humiston, S. G., & Rosenthal, S. L. (2005). Challenges to vaccinating adolescents: Vaccine implementation issues. The Pediatric Infectious Disease Journal, 24(6), S134–S140.CrossRefPubMed
26.
Szilagyi, P. G., Bordley, C., Vann, J. C., Chelminski, A., Kraus, R. M., Margolis, P. A., et al. (2000). Effect of patient reminder/recall interventions on immunization rates: A review. JAMA, 284(14), 1820–1827.CrossRefPubMed
27.
Harris, P. A., Taylor, R., Thielke, R., Payne, J., Gonzalez, N., & Conde, J. G. (2009). Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. Journal of Biomedical Informatics, 42(2), 377–381.CrossRefPubMed
28.
Healy, C. M., Montesinos, D. P., & Middleman, A. B. (2014). Parent and provider perspectives on immunization: Are providers overestimating parental concerns? Vaccine, 32(5), 579–584.CrossRefPubMed
29.
McRee, A., Gilkey, M. B., & Dempsey, A. F. (2014). HPV vaccine hesitancy: Findings from a statewide survey of health care providers. Journal of Pediatric Health Care, 28(6), 541–549.CrossRefPubMedPubMedCentral
30.
Javanbakht, M., Stahlman, S., Walker, S., Gottlieb, S., Markowitz, L., Liddon, N., et al. (2012). Provider perceptions of barriers and facilitators of HPV vaccination in a high-risk community. Vaccine, 30(30), 4511–4516.CrossRefPubMed
31.
Gilkey, M. B., Moss, J. L., Coyne-Beasley, T., Hall, M. E., Shah, P. D., & Brewer, N. T. (2015). Physician communication about adolescent vaccination: How is human papillomavirus vaccine different? Preventive Medicine, 77, 181–185.CrossRefPubMedPubMedCentral
32.
Leddy, M. A., Anderson, B. L., Gall, S., & Schulkin, J. (2009). Obstetrician-gynecologists and the HPV vaccine: practice patterns, beliefs, and knowledge. Journal of Pediatric and Adolescent Gynecology, 22(4), 239–246.CrossRefPubMed
33.
Ko, E. M., Missmer, S., & Johnson, N. R. (2010). Physician attitudes and practice toward human papillomavirus vaccination. Journal of lower genital tract disease, 14(4), 339–345.CrossRefPubMed
34.
Paul, P., & Fabio, A. (2014). Literature review of HPV vaccine delivery strategies: Considerations for school-and non-school based immunization program. Vaccine, 32(3), 320–326.CrossRefPubMed
35.
Brabin, L., Roberts, S. A., Stretch, R., Baxter, D., Chambers, G., Kitchener, H., et al. (2008). Uptake of first two doses of human papillomavirus vaccine by adolescent schoolgirls in Manchester: prospective cohort study. BMJ, 336(7652), 1056–1058.CrossRefPubMedPubMedCentral
36.
Limia, A., & Pachón, I. (2011). Coverage of human papillomavirus vaccination during the first year of its introduction in Spain. Euro Surveill, 16(pii), 19873.
37.
Perkins, R. B., & Clark, J. A. (2012). Providers’ attitudes toward human papillomavirus vaccination in young men challenges for implementation of 2011 recommendations. American Journal of Men’s Health, 6(4), 320–323.CrossRefPubMed
38.
Saraiya, M., Rosser, J. I., & Cooper, C. P. (2012). Cancers that US physicians believe the HPV vaccine prevents: Findings from a physician survey, 2009. Journal of Women’s Health, 21(2), 111–117.CrossRefPubMed
39.
40.
Metadata
Title
Promoting and Providing HPV Vaccination in Hawaii: Barriers Faced by Health Providers
Authors
Ashlyn Tom
Hali Robinett
Lee Buenconsejo-Lum
Reni Soon
Michael Hamilton
Pia Francisco-Natanauan
May Rose Dela Cruz
Ronald Balajadia
Brenda Y. Hernandez
Publication date
01-10-2016
Publisher
Springer US
Published in
Journal of Community Health / Issue 5/2016
Print ISSN: 0094-5145
Electronic ISSN: 1573-3610
DOI
https://doi.org/10.1007/s10900-016-0191-9

Other articles of this Issue 5/2016

Journal of Community Health 5/2016 Go to the issue

Original Paper

Characteristics of Community Newspaper Coverage of Tobacco Control and Its Relationship to the Passage of Tobacco Ordinances

Original Paper

Analyzing the Role of Community and Individual Factors in Food Insecurity: Identifying Diverse Barriers Across Clustered Community Members

Original Paper

Failure of Colonoscopy Knowledge to Predict Colonoscopy Uptake

Original Paper

Energy Drink Use Among Ohio Appalachian Smokers

Original Paper

Using Walk Score™ and Neighborhood Perceptions to Assess Walking Among Middle-Aged and Older Adults

Original Paper

Intestinal Infections Among Febrile Hospitalized Patients in the Republic of Armenia: A Retrospective Chart Review